AssayIndex
Reports by quarter

Reports submitted in 2024-Q1 · page 4

Backfill quarter. Reports assayed earlier were accepted retrospectively where custody could be documented. Median purity for the quarter is 99.23 % area, n=161. Read the 2024-Q1 state-of-the-index report →

161 records5 pagesmedian on this page 99.28 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-004157DesmopressinWWBWWB-2312-E2908Janoshik2024-Q199.645.87101.1Buyer-sourced0PASS
AX-2024-004156DesmopressinWWBWWB-2312-E2908Janoshik2024-Q199.744.81—Laboratory-retained0PASS
AX-2024-004154DesmopressinWWBWWB-2312-E2908PeptideMeter2024-Q199.574.7699.1Buyer-sourced0PASS
AX-2024-004745TB-500HomopeptideHOMO-2308-R3867Janoshik2024-Q199.293.35104.2Buyer-sourced0PASS
AX-2024-004160DesmopressinWWBWWB-2312-E2908Medutest2024-Q199.935.46—Laboratory-retained0PASS
AX-2024-004131SemaxWWBWWB-2308-N1754PeptideMeter2024-Q199.645.6199.7Buyer-sourced0PASS
AX-2024-005208SemaglutideCPCCPC-2309-A1413Medutest2024-Q197.955.10—Buyer-sourced1FAIL
AX-2024-004274PT-141 (Bremelanotide)QSCQSC-2402-X6189Nordanalyt2024-Q199.443.70—Buyer-sourced1FAIL
AX-2024-005179SemaxCPCCPC-2309-M9933PeptideMeter2024-Q198.535.96107.1Buyer-sourced0PASS
AX-2024-004570SemaglutideJEEPJEEP-2308-J8740Medutest2024-Q198.975.0093.5Buyer-sourced0PASS
AX-2024-004746TB-500HomopeptideHOMO-2308-R3867Nordanalyt2024-Q199.413.21106.9Buyer-sourced0PASS
AX-2024-004655RetatrutideTFCTFC-2309-H2397VendorInvestigate2024-Q198.433.6493.7Buyer-sourced0PASS
AX-2024-004653RetatrutideTFCTFC-2309-H2397Medutest2024-Q198.293.41—Laboratory-retained0PASS
AX-2024-005336RetatrutideSIGSIG-2402-5963VendorInvestigate2024-Q198.244.38102.0Buyer-sourced0PASS
AX-2024-004755N-Acetyl Semax AmideHomopeptideHOMO-2401-X5365Medutest2024-Q199.638.98—Buyer-sourced0PASS
AX-2024-004615PT-141 (Bremelanotide)TFCTFC-2310-J1196Janoshik2024-Q199.847.71—Buyer-sourced0PASS
AX-2024-004197IGF-1 LR3WWBWWB-2310-A4053Janoshik2024-Q198.945.1796.0Buyer-sourced0PASS
AX-2024-005180SemaxCPCCPC-2309-M9933Janoshik2024-Q198.696.10—Supplier-supplied0PASS
AX-2024-004738TB-500HomopeptideHOMO-2308-R3867VendorInvestigate2024-Q199.213.26—Buyer-sourced0PASS
AX-2024-004318Melanotan IIQSCQSC-2402-L6963Kestrel2024-Q199.935.3799.9Buyer-sourced0PASS
AX-2024-005311AfamelanotideBCHBCH-2310-K5538Janoshik2024-Q197.805.4290.0Buyer-sourced0FAIL
AX-2024-005175SemaxCPCCPC-2309-M9933Medutest2024-Q198.615.75—Buyer-sourced1MARGINAL
AX-2024-005133GHRP-6SGNSGN-2401-B8456Medutest2024-Q198.913.6993.7Buyer-sourced0FAIL
AX-2024-004659RetatrutideTFCTFC-2309-H2397Medutest2024-Q198.363.87—Buyer-sourced0PASS
AX-2024-004474TirzepatideAMBAMB-2309-P5844Janoshik2024-Q198.235.0890.1Buyer-sourced0PASS
AX-2024-004205IGF-1 LR3WWBWWB-2310-A4053Medutest2024-Q199.845.4189.0Buyer-sourced1MARGINAL
AX-2024-004119SemaxWWBWWB-2308-N1754VendorInvestigate2024-Q199.265.4299.3Buyer-sourced0PASS
AX-2024-004747TB-500HomopeptideHOMO-2308-R3867PeptideMeter2024-Q199.513.4192.5Buyer-sourced0PASS
AX-2024-004322Melanotan IIQSCQSC-2402-L6963Kestrel2024-Q199.935.71—Buyer-sourced0PASS
AX-2024-004200IGF-1 LR3WWBWWB-2310-A4053VendorInvestigate2024-Q199.334.7589.0Buyer-sourced1MARGINAL
AX-2024-004609PT-141 (Bremelanotide)TFCTFC-2310-J1196Medutest2024-Q199.707.95—Laboratory-retained0PASS
AX-2024-004319Melanotan IIQSCQSC-2402-L6963PeptideMeter2024-Q199.515.73100.3Buyer-sourced0PASS
AX-2024-004127SemaxWWBWWB-2308-N1754Janoshik2024-Q199.265.4993.9Buyer-sourced0PASS
AX-2024-004383RetatrutideTFSTFS-{CAT}-9522Janoshik2024-Q198.663.97—Buyer-sourced0PASS
AX-2024-004120SemaxWWBWWB-2308-N1754PeptideMeter2024-Q199.265.23104.7Buyer-sourced0PASS
AX-2024-004128SemaxWWBWWB-2308-N1754Janoshik2024-Q199.415.18—Buyer-sourced0PASS
AX-2024-004618PT-141 (Bremelanotide)TFCTFC-2310-J1196Medutest2024-Q199.718.01—Laboratory-retained0FAIL
AX-2024-004574SemaglutideJEEPJEEP-2308-J8740Nordanalyt2024-Q199.095.44106.4Buyer-sourced0FAIL
AX-2024-005230BPC-157WXTWXT-2312-M2386Janoshik2024-Q197.764.76—Buyer-sourced0FAIL
AX-2024-004744TB-500HomopeptideHOMO-2308-R3867Janoshik2024-Q199.433.4192.9Buyer-sourced0PASS